In this section

Filter by topic:

All Asthma COPD Research Bronchiectasis Lung cancer Obstructive sleep apnoea Housing Smoking Management plans Other conditions Access to primary care Health literacy Poverty Health workforce Social determinants IPF Vaping COVID-19

Airway autoantibodies are determinants of asthma severity:

Brittany Salter, Nan Zhao, Kiho Son, Nadia Suray Tan, Anna Dvorkin-Gheva, Katherine Radford, Nicola LaVigne, Chynna Huang, Melanie Kjarsgaard, Quan-Zhen Li, Konstantinos Tselios, Hui Fang Lim, Nader Khalidi, Parameswaran Nair, Manali Mukherjee

1 December, 2022

NZ Respiratory Research Review Issue 206

Active screening for lung cancer increases smoking abstinence in Australia:

Henry M. Marshall, Mounavi Vemula, Karen Hay, Elizabeth McCaul, Linda Passmore, Ian A. Yang, Rayleen V. Bowman, Kwun M. Fong

27 November, 2022

NZ Respiratory Research Review Issue 205

36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE:

Alexander G.G. Turpie, Alfredo E. Farjat, Sylvia Haas, Uma Maheshwari, Ajay K. Kakkar, on behalf of the GARFIELD-VTE investigators

24 November, 2022

NZ Respiratory Research Review Issue 207

Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial:

Philip A.J. Crosbie, Rhian Gabe, Irene Simmonds, Neil Hancock, Panos Alexandris, Martyn Kennedy, Suzanne Rogerson, David Baldwin, Richard Booton, Claire Bradley, Mike Darby, Claire Eckert, Kevin N. Franks, Jason Lindop, Sam M. Janes, Henrik Møller, Rachael L. Murray, Richard D. Neal, Samantha L. Quaife, Sara Upperton, Bethany Shinkins, Puvan Tharmanathan, Matthew E.J. Callister

24 November, 2022

NZ Respiratory Research Review Issue 205

Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial:

Walter Ageno, Lorenza Bertù, Eugenio Bucherini, Giuseppe Camporese, Francesco Dentali, Matteo Lotti, Gianfranco Lessiani, Roberto Parisi, Paolo Prandoni, Michelangelo Sartori, Adriana Visonà, Elisabetta Bigagli, Gualtiero Palareti, on behalf of the RIDTS study group

23 November, 2022

NZ Respiratory Research Review Issue 207

Associations between COVID-19 and hospitalisation with respiratory and non-respiratory conditions: a record linkage study:

Stacey L Rowe, Karin Leder, Kylie Dyson, Lalitha Sundaresan, Dennis Wollersheim, Brigid Lynch, Ifrah Abdullahi, Benjamin C Cowie, Nicola Stephens, Terence M Nolan, Sheena G Sullivan, Brett Sutton, Allen C Cheng

14 November, 2022

NZ Respiratory Research Review Issue 208

Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series:

Ji Soo Park, Yoo Jung Cho, Je-Yeon Yun, Hye Jin Lee, Jinho Yu, Hyeon-Jong Yang and Dong In Suh1 on behalf of the Korean childhood Asthma REsearch (KARE) team

3 November, 2022

NZ Respiratory Research Review Issue 206

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial:

Ingrid M Bistervels, MD, Andrea Buchmüller, MD, Hanke M G Wiegers, MD, Prof Fionnuala Ní Áinle, MD, Prof Bernard Tardy, MD, Jennifer Donnelly, MD et al.

28 October, 2022

NZ Respiratory Research Review Issue 207

Child maltreatment, anxiety and depression, and asthma among British adults in the UK Biobank:

Yueh-Ying Han, Qi Yan, Wei Chen, Juan C. Celedón

27 October, 2022

NZ Respiratory Research Review Issue 206

Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High–risk Pulmonary Embolism - The CANARY Randomized Clinical Trial:

Parham Sadeghipour, MD; Yaser Jenab, MD; Jamal Moosavi, MD; et al

19 October, 2022

NZ Respiratory Research Review Issue 207